EconPapers    
Economics at your fingertips  
 

Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection

Alex S. Hartlage, Satyapramod Murthy, Arvind Kumar, Sheetal Trivedi, Piyush Dravid, Himanshu Sharma, Christopher M. Walker and Amit Kapoor ()
Additional contact information
Alex S. Hartlage: The Research Institute at Nationwide Children’s Hospital
Satyapramod Murthy: The Research Institute at Nationwide Children’s Hospital
Arvind Kumar: The Research Institute at Nationwide Children’s Hospital
Sheetal Trivedi: The Research Institute at Nationwide Children’s Hospital
Piyush Dravid: The Research Institute at Nationwide Children’s Hospital
Himanshu Sharma: The Research Institute at Nationwide Children’s Hospital
Christopher M. Walker: The Research Institute at Nationwide Children’s Hospital
Amit Kapoor: The Research Institute at Nationwide Children’s Hospital

Nature Communications, 2019, vol. 10, issue 1, 1-11

Abstract: Abstract Efforts to develop an effective vaccine against the hepatitis C virus (HCV; human hepacivirus) have been stymied by a lack of small animal models. Here, we describe an experimental rat model of chronic HCV-related hepacivirus infection and its response to T cell immunization. Immune-competent rats challenged with a rodent hepacivirus (RHV) develop chronic viremia characterized by expansion of non-functional CD8+ T cells. Single-dose vaccination with a recombinant adenovirus vector expressing hepacivirus non-structural proteins induces effective immunity in majority of rats. Resolution of infection coincides with a vigorous recall of intrahepatic cellular responses. Host selection of viral CD8 escape variants can subvert vaccine-conferred immunity. Transient depletion of CD8+ cells from vaccinated rats prolongs infection, while CD4+ cell depletion results in chronic viremia. These results provide direct evidence that co-operation between CD4+ and CD8+ T cells is important for hepacivirus immunity, and that subversion of responses can be prevented by prophylactic vaccination.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-019-09105-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09105-0

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-09105-0

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09105-0